Gabapentin
- Product NDC
- 69844-057
- 11-digit product format
- 698440057
- Labeler code
- 69844
- Product ID
- 69844-057_d877a275-3c42-42e4-b83c-19e65403ddcb
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Gabapentin
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Graviti Pharmaceuticals Private Limited
- Application
- ANDA207099
- Marketing category
- ANDA
- Marketing start
- 2017-03-24
- Marketing end
- 0000-00-00
- Substance
- GABAPENTIN
- Active strength
- 400 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 69844-057-01 | 69844005701 | 30 CAPSULE in 1 BOTTLE (69844-057-01) | 30 capsule | 2017-03-24 | 0000-00-00 | No | No | Current |
| 69844-057-02 | 69844005702 | 100 CAPSULE in 1 BOTTLE (69844-057-02) | 100 capsule | 2017-03-24 | 0000-00-00 | No | No | Current |
| 69844-057-03 | 69844005703 | 1000 CAPSULE in 1 BOTTLE (69844-057-03) | 1000 capsule | 2017-03-24 | 0000-00-00 | No | No | Current |
| 69844-057-04 | 69844005704 | 500 CAPSULE in 1 BOTTLE (69844-057-04) | 500 capsule | 2017-03-24 | 0000-00-00 | No | No | Current |